There was clinical research indicating that the expression level of BCL-2 has positive correlation with some factors which to benefit the prognosis of breast cancer such as progesterone receptor and estrogen receptor, and has negative correlation with the disadvantage ones such as EGFR and the number of metastatic lymph node [9]. The gene discussed is ESR1; the disease is breast carcinoma.